Redifarg 5 & 10 5mg, 10mg Tablets
PDF Leaflet Revision Date: 17 September 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Improves glycaemic control in adults with type 2 diabetes mellitus.
Dosage (summary)
10 mg once daily for adults; no adjustment for elderly or mild renal impairment.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly (u2265 65 years)
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Diuretics may increase risk of dehydration
- Insulin may require dose adjustment
Contraindications
- Type 1 diabetes
- Moderate to severe renal impairment
- Pregnancy
- Breastfeeding
- History of pancreatitis
Common side effects
- Genital infections
- Urinary tract infections
- Hypoglycaemia (with insulin/sulfonylureas)
- Dizziness
Counselling Points
- Monitor for signs of ketoacidosis
- Stay hydrated
- Report any genital or urinary symptoms
Serious warnings
- Risk of diabetic ketoacidosis
- Volume depletion
- Necrotising fasciitis of the perineum
Important Disclaimer
The Redifarg 5 & 10 5mg, 10mg Tablets professional information leaflet below is the property of Dr Reddy’S Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
